Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Child's Nervous System

• Publication date

  2010-03-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00381-010-1106-1PMID 20217098
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural history and management of brainstem gliomas in adults

  2008cited by this paper
• Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience

  2008cited by this paper
• Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma.

  2008cited by this paper
• Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity

  2008cited by this paper
• Treatment options in childhood pontine gliomas

  2006cited by this paper
• Diffuse brainstem glioma in children: critical review of clinical trials.

  2006cited by this paper
• [Treatment results of children and adolescents with brain stem tumours. Own experiences].

  2006cited by this paper
• Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas.

  2006cited by this paper
• Temozolomide Combined with Irradiation as Postoperative Treatment of Primary Glioblastoma Multiforme

  2005cited by this paper
• Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children

  2005cited by this paper
• Primary pediatric brain tumors

  2005cited by this paper
• Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.

  2003cited by this paper
• Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide.

  2002cited by this paper
• Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.

  2002cited by this paper
• Brainstem gliomas in adults: prognostic factors and classification.

  2001cited by this paper
• Radiotherapy followed by high dose busulfan and thiotepa

  2000cited by this paper
• Survival of human glioma cells treated with various combination of temozolomide and X-rays.

  2000cited by this paper
• A clinicopathologic reappraisal of brain stem tumor classification

  2000cited by this paper
• Clinical management of brain stem glioma

  1999cited by this paper
• Chemotherapy for brain stem gliomas

  1999cited by this paper
• There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy.

  1999cited by this paper
• Alternative treatments for childhood brain tumors

  1999cited by this paper
• Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

  1999cited by this paper
• Pediatric brain stem gliomas: a review.

  1998cited by this paper
• DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

  1998cited by this paper
• Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas.

  1998cited by this paper
• Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA

  1998cited by this paper
• In vitro evaluation of temozolomide combined with X-irradiation

  1997cited by this paper
• Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

  1997cited by this paper
• Brain tumors in children.

  1996cited by this paper
• Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome.

  1996cited by this paper
• Brain tumors in children.

  1995cited by this paper
• Topical Review Article: Brainstem Glioma: I. Pathology, Clinical Features, and Therapy

  1993cited by this paper
• Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group.

  1993cited by this paper
• Brainstem glioma: I. Pathology, clinical features, and therapy.

  1993cited by this paper
• Response criteria for phase II studies of supratentorial malignant glioma.

  1990cited by this paper

• Synthesis and Antitumour Evaluation of Tricyclic Indole‐2‐Carboxamides against Paediatric Brain Cancer Cells

  2024cites this paper
• Contemporary Management of Pediatric Brainstem Tumors.

  2024cites this paper
• A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas

  2023cites this paper
• Adult diffuse intrinsic pontine glioma: clinical, radiological, pathological, molecular features, and treatments of 96 patients.

  2022cites this paper
• The Prognostic Impact of Radiotherapy in Conjunction with Temozolomide in Diffuse Intrinsic Pontine Glioma: A Systematic Review and Meta-Analysis.

  2021cites this paper
• Temozolomide and oral etoposide in children with recurrent malignant brain tumors

  2020cites this paper
• Radiation and Chemotherapy for Brainstem Tumors

  2020cites this paper
• Ancestry and frequency of genetic variants in the general population are confounders in the characterization of germline variants linked to cancer

  2020cites this paper
• Efficacy of Temozolomide in Children with Solid Tumors

  2020cites this paper
• Principles of radiation oncology

  2018cites this paper
• Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study.

  2018cites this paper
• Exploring Clinical and Biological Subtypes of Isocitrate Dehydrogenase Mutant Gliomas

  2018cites this paper
• To a question of personalisation opportunities of application of chemotherapy brain tumors on the example of a temozolomid

  2017cites this paper
• Radiotherapy for brainstem gliomas in children and adults: A single‐institution experience and literature review

  2017cites this paper
• Genetic and immune features of resectable malignant brainstem gliomas

  2017cites this paper
• The History and Overview of Pediatric Brain Stem Glioma. 〜Diffuse Intrinsic Pontine Glioma (DIPG)〜

  2016cites this paper
• Radiotherapy Options of Brainstem Tumors

  2015cites this paper
• DIPG in Children – What Can We Learn from the Past?

  2015cites this paper
• Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise?

  2015cites this paper
• Pediatric Brainstem Gliomas: New Understanding Leads to Potential New Treatments for Two Very Different Tumors

  2015cites this paper
• Identification and characterization of novel drugs for the treatment of pediatric gliomas

  2014influential citation
• Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients

  2014cites this paper
• Management of Diffuse Pontine Gliomas in Children: Recent Developments

  2013cites this paper
• Pediatric diffuse intrinsic pontine glioma patients from a single center

  2013cites this paper
• Clinical outcomes and natural history of pediatric brainstem tumors: with 33 cases follow-ups

  2013cites this paper
• Pioneering Preclinical Research in Diffuse Intrinsic Pontine Glioma: Towards New Treatment Strategies

  2012cites this paper
• The use and effectiveness of temozolomide in children with central nervous system tumours: a survey from the Canadian Paediatric Brain Tumour Consortium.

  2011cites this paper
• Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma

  2011cites this paper
• Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.

  2011cites this paper
• A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma.

  2010cites this paper
• First Aid: Diagnosis and Management

  1960cites this paper